Skip to main content

CannTrust Holdings Inc. says John Kaden has resigned as a member of the cannabis company’s board of directors.

The company says Mr. Kaden stepped down to focus on his role as co-founder, managing partner and chief investment officer of Navy Capital Green Management LLC.

CannTrust has been under fire since it disclosed in July that Health Canada had discovered illicit cultivation in unlicensed rooms at its Pelham, Ont., greenhouse.

Story continues below advertisement

The company later fired its chief executive officer “with cause” and asked its chairman to resign after the board discovered new information during an internal investigation. Health Canada suspended CannTrust’s licences to produce and sell cannabis in September.

Mr. Kaden joined the CannTrust board in October, 2018, and served as a member of the special committee that investigated the causes of the company’s non-compliance with Health Canada regulations.

The special committee recently completed its investigation and the company submitted a detailed remediation plan to Health Canada in hopes of regaining its cannabis licences.

“With its remediation plan now underway, I believe CannTrust is well positioned to fulfill its commitments to both bring the company into full regulatory compliance and seek the full reinstatement of its licenses,” Mr. Kaden said in a statement.

Report an error
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies